Literature DB >> 15937289

Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome.

Rosario Menéndez1, Antoni Torres, Rafael Zalacaín, Javier Aspa, Juan J Martín-Villasclaras, Luis Borderías, José M Benítez-Moya, Juan Ruiz-Manzano, Felipe Rodríguez de Castro, José Blanquer, Diego Pérez, Carmen Puzo, Fernando Sánchez-Gascón, José Gallardo, Carlos Alvarez, Luis Molinos.   

Abstract

RATIONALE: Some studies highlight the association of better clinical responses with adherence to guidelines for empiric treatment of community-acquired pneumonia (CAP), but little is known about factors that influence this adherence.
OBJECTIVES: Our objectives were to identify factors influencing adherence to the guidelines for empiric treatment of CAP, and to evaluate the impact of adherence on outcome.
METHODS: We studied 1,288 patients with CAP admitted to 13 Spanish hospitals. Collected variables included the patients' clinical and demographic data, initial severity of the disease, antibiotic treatment, and specialty and training status of the prescribing physician.
MEASUREMENTS AND MAIN RESULTS: Adherence to guidelines was high (79.7%), with significant differences between hospitals (range, 47-97%) and physicians (pneumologists, 81%; pneumology residents, 84%; nonpneumology residents, 82%; other specialists, 67%). The independent factors related to higher adherence were hospital, physician characteristics, and initial high-risk class of Fine, whereas admission to intensive care unit decreased adherence. Seventy-four patients died (6.1%), and treatment failure was found in 175 patients (14.2%). After adjusting for Fine risk class, adherence to the guidelines was found protective for mortality (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.3-0.9) and for treatment failure (OR, 0.65; 95% CI, 0.5-0.9). Treatment prescribed by pneumologists and residents was associated with lower treatment failure (OR, 0.6; 95% CI, 0.4-0.9).
CONCLUSIONS: Adherence to guidelines mainly depends on the hospital and the specialty and training status of prescribing physicians. Nonadherence was higher in nonpneumology specialists, and is an independent risk factor for treatment failure and mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15937289     DOI: 10.1164/rccm.200411-1444OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

Review 1.  Community acquired pneumonia: assessment and treatment.

Authors:  Caroline M Patterson; Michael R Loebinger
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

2.  Categorical Risk Perception Drives Variability in Antibiotic Prescribing in the Emergency Department: A Mixed Methods Observational Study.

Authors:  Eili Y Klein; Elena M Martinez; Larissa May; Mustapha Saheed; Valerie Reyna; David A Broniatowski
Journal:  J Gen Intern Med       Date:  2017-06-20       Impact factor: 5.128

3.  Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay.

Authors:  L A Ruiz; A Gómez; C Jaca; L Martínez; B Gómez; R Zalacain
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

4.  Patients' and Clinicians' Perceptions of Antibiotic Prescribing for Upper Respiratory Infections in the Acute Care Setting.

Authors:  David A Broniatowski; Eili Y Klein; Larissa May; Elena M Martinez; Chelsea Ware; Valerie F Reyna
Journal:  Med Decis Making       Date:  2018-07       Impact factor: 2.583

5.  Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality.

Authors:  Elisa Costantini; Elias Allara; Filippo Patrucco; Fabrizio Faggiano; Fozia Hamid; Piero Emilio Balbo
Journal:  Intern Emerg Med       Date:  2016-04-20       Impact factor: 3.397

6.  Community acquired pneumonia: severity scores as an adjunct to clinical judgement.

Authors:  P J Marcos; M I Restrepo; H Verea
Journal:  Eur Respir J       Date:  2012-02       Impact factor: 16.671

7.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

8.  Discordance of physician clinical judgment vs. pneumonia severity index (PSI) score to admit patients with low risk community-acquired pneumonia: a prospective multicenter study.

Authors:  Pedro J Marcos; Marcos I Restrepo; Francisco J González-Barcala; Nilam J Soni; Iria Vidal; Pilar Sanjuàn; Diego Llinares; Lucía Ferreira-Gonzalez; Carlos Rábade; Isabel Otero-González; Pedro Marcos; Héctor Verea-Hernando
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

9.  Do hospitals provide lower quality of care to black patients for pneumonia?

Authors:  Florian B Mayr; Sachin Yende; Gina D'Angelo; Amber E Barnato; John A Kellum; Lisa Weissfeld; Donald M Yealy; Michael C Reade; Eric B Milbrandt; Derek C Angus
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

10.  Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: a cohort study.

Authors:  Angela L P Chow; David C Lye; Onyebuchi A Arah
Journal:  J Am Med Inform Assoc       Date:  2015-09-05       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.